the aid library

LIST OPTIONS

Filter

2681

Download (449)

View PDF (514)

Improving Brain Tumor Research in Resource-Limited Countries: A Review of the Literature Focusing on West Africa

S. I. Ngulde; F. Fezeu; A.Ramesh; et al. PMC; Cureus (2015) C2

Cureus. 2015 Nov; 7(11): e372. Published online 2015 Nov 3. doi: 10.7759/cureus.372 PMCID: PMC4671837 PMID: 26677422

Download (339)

View PDF (275)

The Malawi Noncommunicable Diseases & Injuries Poverty Commission Report

Republic of Malawi; Ministry of Health (2018) CC2

As our world changes, so too does the burden of disease. Globalisation, evolving trade and consumption patterns, and increased access to life-saving medical care are just some of the factors that have transformed the global health landscape.

Download (412)

View PDF (544)

Haiti: Flash appeal - Earthquake August 2021

UN Office for the Coordination of Humanitarian Affairs OCHA (2021) CC

Strategical plan

Download (417)

View PDF (489)

Global Report on assistive technology
recommended

World Health Organization WHO (2022) C_WHO

The report notes that the number of people in need of one or more assistive products is likely to rise to 3.5 billion by 2050, due to populations ageing and the prevalence of noncommunicable diseases rising across the world. The report also highlights the vast gap in access between low- and high-inc... more

Download (360)

View PDF (363)

National strategic Plan for the Prevention and Control of Non-Communicable diseases 2020-2025; South Africa National NCD Strategic Plan

World Health Organization WHO (2020) C_WHO

Non-Communicable Diseases (NCDs), including mental disorders, currently pose one of the biggest threats to health and development globally, particularly in low and middle income countries2. It is predicted that unless proven interventions are rapidly implemented in countries, in the short to medium ... more

Download (461)

View PDF (492)

Abordar la violencia contra las mujeres en las políticas y los protocolos de salud de la Región de las Américas. Un informe de la situación regional

World Health Organisation (WHO) (2023) C_WHO

La violencia contra las mujeres y las niñas es generalizada en la Región de las Américas, y tiene enormes consecuencias para su salud y bienestar, así como el de sus familias y sus comunidades. Se trata de un costo inaceptable que puede ser prevenido mediante acciones basadas en la evidencia, pr... more

Download (913)

View PDF (1290)

Ghana Demographic and Health Survey 2014

Ghana Statistical Service; Ghana Health Service, ICF DHS Program; USAID (2015) C1

Download (551)

View PDF (843)

Global spending on health: Weathering the storm

World Health Organization WHO (2020) C_WHO

The 2020 Report analyzes global health spending for 190 countries from 2000 to 2018 and provides insights as to the health spending trajectory from the MDG era to the SDG era prior to the crisis of 2020. The report shows that global spending on health continually rose between 2000 and 2018 and reach... more

Download (306)

View PDF (462)

Benin: Rapid Assessment of Sexual and Reproductive Health and HIV Linkages

IPPF, UNFPA, WHO, UNAIDS (2011) C2

This summary highlights the experiences, results and actions from the implementation of the Rapid Assessment Tool for Sexual and The tool – developed by IPPF, UNFPA, WHO, UNAIDS, GNP+, ICW and Young Positives in 2009 – supports national assessments of the bi-directional linkages between sexu... more

Download (5914)

View PDF (7660)

Common Skin Diseases In Africa: An Illustrated Guide
recommended

Colette van Hees and Ben Naafs (2004) C1

Download (3026)

View PDF (6683)

The Johns Hopkins and Red Cross Red Crescent Public Health Guide in Emergencies
recommended

Johns Hopkins Bloomberg School of Public Health and International Federation of Red Cross and Red Crescent Societies (2008) C1

2nd edition. Essential guideline for humanitarian assistance

Download (400)

View PDF (395)

Optimizing active case-finding for tuberculosis

World Health Organization. Regional Office for South-East Asia (2021) C_WHO

he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appropriately implemented, the activity is cost effectiv... more

Download (389)

View PDF (597)

Global expenditure on health: Public spending on the rise?

World Health Organisation (WHO) (2021) C_WHO

The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (i... more

Download (303)

View PDF (244)

Global Strategy for Asthma Management and Prevention (2023 update)

Global Initiative for Asthma (2023) CC2

Asthma is a serious global health problem affecting all age groups. Its prevalence is increasing in many countries, espacially among children. Although some countries have seen a decline in hospitalizations and deaths from asthma, asthma still imposes an unacceptable burden on health care systems, a... more

Download (521)

View PDF (754)

Neisseria gonorrhoeae Antimicrobial Resistance Surveillance: Consolidated Guidance

World Health Organization WHO (2020) C_WHO

Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas... more

Download (362)

View PDF (368)

National Antenatal Sentinel HIV Survey Key Findings, South Africa 2017

south (2019) CC

Download (443)

View PDF (560)

South-East Asia Regional Action Plan on Programmatic Management of Latent Tuberculosis Infection

World Health Organization (WHO), Regional Office for South-East Asia (2020) C_WHO

Download (639)

View PDF (447)

National Guidelines for Integrated Diseases Surveillance and Response Uganda

World Health Organization WHO, Regional Office of Africa; Ministry of Health Uganda (2021) C_WHO

3rd edition. In 2001, Uganda adapted the Integrated Disease Surveillance and Response (IDSR) developed by World Health Organization (WHO) for member states in African region. The Ministry of Health has been implementing the IDSR strategy since then with success across the country. This strategy prov... more

Download (595)

View PDF (788)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Global Report on assistive technology recommended

Common Skin Diseases In Africa: An Illustrated Guide recommended

The Johns Hopkins and Red Cross Red Crescent Public Health Guide in Emergencies recommended

Global Report on assistive technology
recommended

Common Skin Diseases In Africa: An Illustrated Guide
recommended

The Johns Hopkins and Red Cross Red Crescent Public Health Guide in Emergencies
recommended